76 related articles for article (PubMed ID: 27684202)
1. Curacin E from the Brittle Star Ophiocoma scolopendrina.
Ueoka R; Hitora Y; Ito A; Yoshida M; Okada S; Takada K; Matsunaga S
J Nat Prod; 2016 Oct; 79(10):2754-2757. PubMed ID: 27684202
[TBL] [Abstract][Full Text] [Related]
2. Curacin D, an antimitotic agent from the marine cyanobacterium Lyngbya majuscula.
Márquez B; Verdier-Pinard P; Hamel E; Gerwick WH
Phytochemistry; 1998 Dec; 49(8):2387-9. PubMed ID: 9887531
[TBL] [Abstract][Full Text] [Related]
3. Characterization of the interaction of the marine cyanobacterial natural product curacin A with the colchicine site of tubulin and initial structure-activity studies with analogues.
Blokhin AV; Yoo HD; Geralds RS; Nagle DG; Gerwick WH; Hamel E
Mol Pharmacol; 1995 Sep; 48(3):523-31. PubMed ID: 7565634
[TBL] [Abstract][Full Text] [Related]
4. Structure-activity analysis of the interaction of curacin A, the potent colchicine site antimitotic agent, with tubulin and effects of analogs on the growth of MCF-7 breast cancer cells.
Verdier-Pinard P; Lai JY; Yoo HD; Yu J; Marquez B; Nagle DG; Nambu M; White JD; Falck JR; Gerwick WH; Day BW; Hamel E
Mol Pharmacol; 1998 Jan; 53(1):62-76. PubMed ID: 9443933
[TBL] [Abstract][Full Text] [Related]
5. Biosynthesis of radiolabeled curacin A and its rapid and apparently irreversible binding to the colchicine site of tubulin.
Verdier-Pinard P; Sitachitta N; Rossi JV; Sackett DL; Gerwick WH; Hamel E
Arch Biochem Biophys; 1999 Oct; 370(1):51-8. PubMed ID: 10496976
[TBL] [Abstract][Full Text] [Related]
6. Chemistry and biology of curacin A.
Wipf P; Reeves JT; Day BW
Curr Pharm Des; 2004; 10(12):1417-37. PubMed ID: 15134491
[TBL] [Abstract][Full Text] [Related]
7. Biosynthetic pathway and gene cluster analysis of curacin A, an antitubulin natural product from the tropical marine cyanobacterium Lyngbya majuscula.
Chang Z; Sitachitta N; Rossi JV; Roberts MA; Flatt PM; Jia J; Sherman DH; Gerwick WH
J Nat Prod; 2004 Aug; 67(8):1356-67. PubMed ID: 15332855
[TBL] [Abstract][Full Text] [Related]
8. Constituents of ophiuroidea. 1. Isolation and structure of three ganglioside molecular species from the brittle star Ophiocoma scolopendrina.
Inagaki M; Shibai M; Isobe R; Higuchi R
Chem Pharm Bull (Tokyo); 2001 Dec; 49(12):1521-5. PubMed ID: 11767069
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and biological evaluation of structurally highly modified analogues of the antimitotic natural product curacin A.
Wipf P; Reeves JT; Balachandran R; Day BW
J Med Chem; 2002 Apr; 45(9):1901-17. PubMed ID: 11960501
[TBL] [Abstract][Full Text] [Related]
10. Syntheses of polybrominated indoles from the red alga Laurencia brongniartii and the brittle star Ophiocoma erinaceus.
Liu Y; Gribble GW
J Nat Prod; 2002 May; 65(5):748-9. PubMed ID: 12027758
[TBL] [Abstract][Full Text] [Related]
11. A mathematical model of in vitro cancer cell growth and treatment with the antimitotic agent curacin A.
Kozusko F; Chen P; Grant SG; Day BW; Panetta JC
Math Biosci; 2001 Mar; 170(1):1-16. PubMed ID: 11259801
[TBL] [Abstract][Full Text] [Related]
12. Metabolic coupling of dehydration and decarboxylation in the curacin A pathway: functional identification of a mechanistically diverse enzyme pair.
Gu L; Jia J; Liu H; Håkansson K; Gerwick WH; Sherman DH
J Am Chem Soc; 2006 Jul; 128(28):9014-5. PubMed ID: 16834357
[TBL] [Abstract][Full Text] [Related]
13. Ophiodilactones A and B, cytotoxic tetrameric phenylpropanoids, from the ophiuroid Ophiocoma scolopendrina.
Ueoka R; Fujita T; Matsunaga S
J Org Chem; 2009 Jun; 74(11):4396-9. PubMed ID: 19432399
[TBL] [Abstract][Full Text] [Related]
14. A new 2,3-dimethyl butenolide from the brittle star Ophiomastix mixta.
Lee J; Wang W; Hong J; Lee CO; Shin S; Im KS; Jung JH
Chem Pharm Bull (Tokyo); 2007 Mar; 55(3):459-61. PubMed ID: 17329891
[TBL] [Abstract][Full Text] [Related]
15. The p53 Modulated Cytotoxicity of
Amini E; Baharara J; Afzali M; Nikdel N
Avicenna J Med Biotechnol; 2019; 11(3):208-214. PubMed ID: 31379992
[TBL] [Abstract][Full Text] [Related]
16. Heterologous production of 4-O-demethylbarbamide, a marine cyanobacterial natural product.
Kim EJ; Lee JH; Choi H; Pereira AR; Ban YH; Yoo YJ; Kim E; Park JW; Sherman DH; Gerwick WH; Yoon YJ
Org Lett; 2012 Dec; 14(23):5824-7. PubMed ID: 23148802
[TBL] [Abstract][Full Text] [Related]
17. Wewakazole B, a Cytotoxic Cyanobactin from the Cyanobacterium Moorea producens Collected in the Red Sea.
Lopez JA; Al-Lihaibi SS; Alarif WM; Abdel-Lateff A; Nogata Y; Washio K; Morikawa M; Okino T
J Nat Prod; 2016 Apr; 79(4):1213-8. PubMed ID: 26980238
[TBL] [Abstract][Full Text] [Related]
18. Continuing studies on the cyanobacterium Lyngbya sp.: isolation and structure determination of 15-norlyngbyapeptin A and lyngbyabellin D.
Williams PG; Luesch H; Yoshida WY; Moore RE; Paul VJ
J Nat Prod; 2003 May; 66(5):595-8. PubMed ID: 12762789
[TBL] [Abstract][Full Text] [Related]
19. Laucysteinamide A, a Hybrid PKS/NRPS Metabolite from a Saipan Cyanobacterium, cf. Caldora penicillata.
Zhang C; Naman CB; Engene N; Gerwick WH
Mar Drugs; 2017 Apr; 15(4):. PubMed ID: 28420100
[TBL] [Abstract][Full Text] [Related]
20. Barbamide, a chlorinated metabolite with molluscicidal activity from the Caribbean cyanobacterium Lyngbya majuscula.
Orjala J; Gerwick WH
J Nat Prod; 1996 Apr; 59(4):427-30. PubMed ID: 8699186
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
